Prognosis
New Monkeypox Shot Technique to Get Emergency US Approval to Extend Supply
- Approach uses one-fifth the amount of vaccine as standard
- Authorization also allows Jynneos to be used in some children
A health worker administers a dose of the Bavarian Nordic A/S Jynneos monkeypox vaccine in West Hollywood, California, on Aug. 3.
Photographer: Jill Connelly/BloombergThis article is for subscribers only.
US health officials are issuing emergency clearance to a technique for extending the supply of monkeypox vaccine made by Bavarian Nordic A/S amid ongoing shortages.
The action will allow the US Food and Drug Administration to “exercise additional authorities that may increase availability of vaccines to prevent monkeypox while continuing to ensure the vaccine meets high standards for safety, effectiveness and manufacturing quality,” Department of Health and Human Services Secretary Xavier Becerra said in a statement.